Possible renoprotective mechanisms of SGLT2 inhibitors

Possible renoprotective mechanisms of SGLT2 inhibitors

Treatment with a sodium glucose cotransporter 2 (SGLT2) inhibitor in patients with chronic kidney disease reduces the renal risk independent of changes in blood glucose concentrations and blood pressure. However, the precise mechanism responsible for this SGLT2 inhibitor-induced renoprotective effec...

Full description

Bibliographic Details
Main Authors: Akira Nishiyama, Kento Kitada
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Medicine
Subjects:
SGLT2 inhibitor
chronic kidney disease (CKD)
diabetic kidney disease (DKD)
renal function
metabolism
aestivation-like response
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1115413/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1115413/full

Similar Items